1. Home

MHRA approves melatonin solution for children and adolescents with ADHD

 
• By Valeria Fiore

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Colonis’ Melatonin 1mg/ml Oral Solution as a treatment to improve sleep in children and adolescents with attention-deficit hyperactivity disorder (ADHD), the manufacturer has announced.

Insomnia
Children with ADHD are more likely to suffer from sleep onset insomnia

Latest from News

More from Clinical